Basit öğe kaydını göster

dc.contributor.authorSenocak, M
dc.contributor.authorTuzuner, N
dc.contributor.authorFerhanoglu, B
dc.contributor.authorOzen, S
dc.date.accessioned2021-03-03T11:39:49Z
dc.date.available2021-03-03T11:39:49Z
dc.date.issued1997
dc.identifier.citationOzen S., Ferhanoglu B., Senocak M., Tuzuner N., "Idiopathic myelofibrosis (agnogenic myeloid metaplasia): Clinicopathological analysis of 32 patients", LEUKEMIA RESEARCH, cilt.21, sa.2, ss.125-131, 1997
dc.identifier.issn0145-2126
dc.identifier.otherav_292b56a3-a161-4ed2-9dd9-414d6b4bdf8c
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/32516
dc.identifier.urihttps://doi.org/10.1016/s0145-2126(96)00095-1
dc.description.abstractThe prognostic value of clinicopathological parameters, recorded at diagnosis, in idiopathic myelofibrosis (IMF) was retrospectively analyzed in a consecutive series of 32 patients followed for a minimum of 5 and maximum of 134 months in the period 1983-1994. Of the 32 patients, 18 were males and 14 were females. The mean age was 59.8 years (S.D., 10.4; range, 44-78 years). At the time of closure of the study (May 1995), 10 patients were dead, 18 were alive, and four were lost to follow up. The mean survival was 41 months (range 2-130 months).
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectHEMATOLOJİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.titleIdiopathic myelofibrosis (agnogenic myeloid metaplasia): Clinicopathological analysis of 32 patients
dc.typeMakale
dc.relation.journalLEUKEMIA RESEARCH
dc.contributor.department, ,
dc.identifier.volume21
dc.identifier.issue2
dc.identifier.startpage125
dc.identifier.endpage131
dc.contributor.firstauthorID118499


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster